2477. Recent Trials in Non-HIV Antivirals
Session: Symposium: New Anti-Infective Clinical Trials that Will Change Your Practice
Saturday, October 7, 2017: 2:00 PM
Room: 11AB
Francisco M. Marty, MD, FIDSA, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA


Disclosures:

F. M. Marty, Astellas Pharma US: Consultant and Grant Investigator , Consulting fee and Grant recipient
Chimerix: Consultant and Grant Investigator , Consulting fee and Grant recipient
Fate Therapeutics: Scientific Advisor , Consulting fee
Gilead Sciences: Consultant and Grant Investigator , Consulting fee and Grant recipient
LFB: Consultant , Consulting fee
Merck: Consultant , Grant Investigator and Scientific Advisor , Consulting fee and Grant recipient
Roche Molecular Systems: Consultant , Consulting fee
Shire: Consultant and Grant Investigator , Consulting fee and Grant recipient

Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.